These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37470789)

  • 1. Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG).
    Adams AD; Fiesco-Roa MÓ; Wong L; Jenkins GP; Malinowski J; Demarest OM; Rothberg PG; Hobert JA;
    Genet Med; 2023 Sep; 25(9):100358. PubMed ID: 37470789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
    Lowe TB; DeLuca J; Arnold GL
    Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.
    Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A;
    Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
    Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic etiology and clinical challenges of phenylketonuria.
    Elhawary NA; AlJahdali IA; Abumansour IS; Elhawary EN; Gaboon N; Dandini M; Madkhali A; Alosaimi W; Alzahrani A; Aljohani F; Melibary EM; Kensara OA
    Hum Genomics; 2022 Jul; 16(1):22. PubMed ID: 35854334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study.
    Bratkovic D; Margvelashvili L; Tchan MC; Nisbet J; Smith N
    Metabolism; 2022 Mar; 128():155116. PubMed ID: 34973284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia.
    Item CB; Farhadi S; Schanzer A; Greber-Platzer S
    Clin Biochem; 2017 Aug; 50(12):729-732. PubMed ID: 28389235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
    Burton BK; Longo N; Vockley J; Grange DK; Harding CO; Decker C; Li M; Lau K; Rosen O; Larimore K; Thomas J;
    Mol Genet Metab; 2020 Aug; 130(4):239-246. PubMed ID: 32593547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.
    Rohr F; Burton B; Dee A; Harding CO; Lilienstein J; Lindstrom K; MacLeod E; Rose S; Singh R; van Calcar S; Whitehall K
    Mol Genet Metab; 2024 Mar; 141(3):108122. PubMed ID: 38184920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal PKU: Defining phenylalanine tolerance and its variation during pregnancy, according to genetic background.
    Caletti MT; Bettocchi I; Baronio F; Brodosi L; Cataldi S; Petroni ML; Cassio A; Marchesini G
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):977-983. PubMed ID: 32409273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria.
    Elsas LJ; Greto J; Wierenga A
    Mol Genet Metab; 2011 Apr; 102(4):407-12. PubMed ID: 21216643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of eventual requirement of phenylalanine-restricted diet in young infants with phenylalanine hydroxylase deficiency initially managed with sapropterin monotherapy.
    Çıkı K; Yıldız Y; Kahraman AB; Özgül RK; Coşkun T; Dursun A; Tokatlı A; Sivri S
    Mol Genet Metab; 2023 Nov; 140(3):107706. PubMed ID: 37837865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta-analysis of randomized controlled trials.
    Qu J; Yang T; Wang E; Li M; Chen C; Ma L; Zhou Y; Cui Y
    Br J Clin Pharmacol; 2019 May; 85(5):893-899. PubMed ID: 30720885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):e167-e170. PubMed ID: 32217978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion Summary, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):987-988. PubMed ID: 32217972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis.
    Zimmermann M; Jacobs P; Fingerhut R; Torresani T; Thöny B; Blau N; Baumgartner MR; Rohrbach M
    Mol Genet Metab; 2012 Jul; 106(3):264-8. PubMed ID: 22607939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis.
    Foreman PK; Margulis AV; Alexander K; Shediac R; Calingaert B; Harding A; Pladevall-Vila M; Landis S
    Orphanet J Rare Dis; 2021 Jun; 16(1):253. PubMed ID: 34082800
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.